Summit Therapeutics
Focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
| N/A | N/A | IPO | |
$4.5m | Grant | ||
| N/A | $64.0m | Grant | |
$8.8m | Grant | ||
* | N/A | $500m | Post IPO Equity |
* | N/A | $200m | Post IPO Equity |
* | $235m | Post IPO Equity | |
| Total Funding | €70.3m | ||
Related Content
Recent News about Summit Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.